Skip to main content

1 Result(s)

within A Demols Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

    Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to evaluate the activity and tolerability of this combination in patients refractory to ...

    A Demols, M Peeters, M Polus, R Marechal, F Gay, E Monsaert… in British Journal of Cancer (2006)

    Download PDF (103 KB) View Article